Topiramate for intractable childhood epilepsy

Seizure

Volumn 8, Issue 1, 1999, Pages 38-40

  Moreland, Elaine C ^a   Griesemer, David A ^a,b   Holden, Kenton R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antiepileptic drug; Children; Epilepsy; Topiramate

Indexed keywords

CARBAMAZEPINE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ALERTNESS; ANOREXIA; ARTICLE; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMPLEX PARTIAL SEIZURE; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; GRAND MAL SEIZURE; HUMAN; INSOMNIA; INTRACTABLE EPILEPSY; LEARNING DISORDER; MALE; PATIENT MONITORING; PEDIATRICS; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; SPEECH DISORDER;

EID: 0033013762     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.1998.0212     Document Type: Article

References (5)

1. Rosenfeld, W. E. Topiramate: A review of preclinical, pharmacokinetic, and clinical data. Clinical Therapeutics 1997; 19: 1294-1308.
2. Glauser, T. A. Preliminary observations on topiramate in pediatrie epilepsies. Epilepsia 1997; 38 (Suppl. 1): S37-S41.
3. Ben-Menachem, E., Henriksen, O., Dam, M. et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996; 37: 539-543.
4. Privitera, M., Finchan, R., Penry, J., Reige, R., Kramer, L., Pledger, G, Karim, R. and the Topiramate YE Study Group. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1000-mg daily dosages. Neurology 1996; 46: 1678-1683.
5. Faught, E., Wilder, B. J., Ramsay, R. E., Reife, R. A., Kramer, L. D., Pledger, G. W., Karim, R. M. and the Topiramate YD Study Group. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 1996; 46: 1684-1690.